Recent Headlines & Media Mentions
Company News
Michigan woman living with motor neuron disease uses brain activity to generate her own words, answer open-ended questions, and communicate with family using the fully implanted intracortical BCI
Paradromics' brain-computer interface shows 4+ years of stable neural recording and decoding in preclinical studies, combining performance with durability.
Aug 26, 2026
Paradromics Receives FDA Approval to Expand BCI Access to Personal Computing Devices in Connect-One™ Clinical Study
Expanded device pathway advances development of the Paradromics BCI platform toward greater mobility, independence, and everyday digital access
Neurologist, clinical scientist, and former Verily leader joins Paradromics as company advances first-in-human clinical study
The Connect-One Early Feasibility Study will evaluate the long term use of the Connexus BCI to safely restore speech and enable computer control for people with severe motor impairment
Thought Leadership
Looking for additional insights, industry findings, and scientific deep dives?